Mraz Amerine & Associates’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$175K Hold
11,000
0.03% 182
2026
Q1
$149K Hold
11,000
0.02% 176
2025
Q4
$137K Hold
11,000
0.02% 180
2025
Q3
$109K Hold
11,000
0.02% 177
2025
Q2
$98.2K Sell
11,000
-1,000
-8% -$8.46K 0.02% 181
2025
Q1
$104K Sell
12,000
-200
-2% -$2.1K 0.02% 158
2024
Q4
$152K Buy
12,200
+200
+2% +$2.46K 0.03% 154
2024
Q3
$139K Hold
12,000
0.03% 159
2024
Q2
$128K Hold
12,000
0.03% 158
2024
Q1
$143K Hold
12,000
0.03% 167
2023
Q4
$130K Buy
+12,000
New +$115K 0.03% 167

Other funds holding VTRS

Mraz Amerine & Associates's VTRS Position: Q2 2026 in Review

Mraz Amerine & Associates held its Viatris (VTRS) position steady in Q2 2026 at 11,000 shares worth $175K. The position accounts for 0.03% of the portfolio, ranked #182.

Mraz Amerine & Associates first reported a position in VTRS in Q4 2023 and has held it in 11 quarters since. 1,026 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Mraz Amerine & Associates held 11,000 shares of Viatris worth $175K as of Q2 2026.
  • Mraz Amerine & Associates left its Viatris share count unchanged in Q2 2026.
  • Viatris made up 0.03% of Mraz Amerine & Associates's portfolio in Q2 2026, its #182 holding.
  • Mraz Amerine & Associates first reported a position in Viatris in Q4 2023 and has held it in 11 quarters since.
  • 1,026 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Mraz Amerine & Associates's 13F filing for Q2 2026, filed 16 Jul 2026.